IDEC-C2B8 ( Rituximab ) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma.
12.
Monoclonal antibody therapy is another strategy in which the therapeutic agent is an antibody which specifically binds to a protein on the surface of the cancer cells.
13.
The recent success of antibody therapies, such as Herceptin for the treatment of breast cancer, has made them a hot area of research for drug makers.
14.
Complement proteins protect against malignant cells-both by direct complement attack and through initiation of Complement-dependent cytotoxicity, which synergises with specific monoclonal antibody therapies.
15.
These conjugates are used in immunotherapy and to develop monoclonal antibody therapy as a targeted form of chemotherapy when they are often known as antibody-drug conjugates.
16.
They are largely built from parts of antibodies ( immunoglobulins ), and like them have a binding site for antigens that could be used for monoclonal antibody therapy.
17.
The cost of treatment with a typical monoclonal antibody therapy for relatively common indications is generally in the range of ?7, 000 14, 000 per patient per year.
18.
The prostate cancer drug, known as anti-PSMA, is a monoclonal antibody therapy that seeks out and attaches to an antigen found on the surface of prostate cancer cells.
19.
He pursued a research career in haematology and immunology, successively becoming an expert in plasma exchange, stem cell transplantation, monoclonal antibody therapy, myelodysplastic syndrome and chronic lymphocytic leukaemia.
20.
Chemotherapy with agents such as cyclophosphamide may also be effective but has more toxicity than ATG . Antibody therapy, such as ATG, targets T-cells, which are believed to attack the bone marrow.
